Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Birmex Anti-scorpion Serum vs Alacramyn in Children
NCT01415830Phase 3Completed
- Sponsor
- BIRMEX
- Start
- Aug 2011
- Primary completion
- May 2012
- Modality
- Antibody Conjugates, Vaccines & Immunotherapeutics, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 3, randomised trial of Birmex in scorpion envenomation (2 arms), sponsored by BIRMEX. Primary endpoint: Resolution of signs and symptoms of scorpion envenomation at 12 hours. Started Aug 2011; status: completed.
02
Drugs
Birmex
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT01415830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415830.